Objective: Assess within-subject agreement and compare discriminative abilities between the SF-6D and the Health Utilities Index Mark 3 (HUI3) in patients with chronic kidney disease (CKD). Methods: The HUI3 and Short Form-36 were self-completed by 185 CKD patients enrolled in a prospective study of incident patients with stage 4 and 5 CKD. Results: The mean preference-based score for the SF-6D was 0.67 Ϯ 0.13 compared to 0.58 Ϯ 0.26 for the HUI3 (P < 0.01). There was a strong association between SF-6D and HUI3 scores (Pearson correlation coefficient 0.55, 95% CI 0.43-0.65) and moderate agreement with an intraclass correlation coefficient of 0.44. The HUI3 was better able to capture more severe burden of illness with fewer floor effects. The SF-6D was better at capturing differences among patients at the top range of the scale with fewer ceiling effects. Both the HUI3 and SF-6D were able to discriminate between patient groups differing in disease severity defined as predialysis versus dialysis dependent and depressive symptoms using a Beck Depression Inventory II score of Ն14 as the cutoff. The HUI3 was better able to discriminate greater depressive symptoms. Conclusion: The SF-6D and the HUI3 generate different preference-based scores for patients with CKD and any comparison between their scores should be made with caution. The HUI3 appears more suitable for measuring the health of populations with greater disability such as patients with CKD. It remains to be determined whether these differences will remain when one compares within-instrument differences in preference scores over time.
Introduction
The ever-increasing demands on health-care systems have stimulated much interest in the cost-effectiveness of health-care interventions. An important technique for assessing cost-effectiveness has been cost-utility analysis, which incorporates preferences for different health states and provides estimates of quality adjusted survival, expressed as quality-adjusted life-years (QALYs).
Establishing the net effect of an intervention on health-related quality of life (HRQL) in a single summary score is essential for cost-effectiveness and cost-utility analyses. Nevertheless, this is difficult to do with the standard HRQL measures used in studies of patients with chronic kidney disease (CKD), such as the Short Form-36 (SF-36) [1] or the Kidney Disease Quality of Life (KDQOL) questionnaire [2] . The SF-36 and the KDQOL were not developed to generate a single summary score. Furthermore, to estimate the QALYs gained by those who receive an intervention, the scoring system needs to be able to integrate mortality and morbidity. Although the scores derived from the KDQOL and SF-36 reflect morbidity, the scores do not reflect mortality.
The health state values used to derive QALYs can be obtained from multiattribute preference-based HRQL instruments such as the Health Utilities Index Mark 3 (HUI3) and the SF-6D [3] [4] [5] . These systems employ multidomain health-status questionnaires completed by patients to obtain information on self-assessed health status. Preference-based scores for those health states are then calculated using published scoring functions for the two systems. The published scoring functions are based on preferences obtained from random samples of the general population, the United Kingdom for SF-6D [5] and Canada for HUI3 [4] . The preference-based score for each state is then used to calculate QALYs by multiplying the score for that health state by the time that the patient spends in that particular health state. These multiattribute preference-based instruments are significantly less resource and time-consuming than direct utility or preference elicitation approaches, such as the standard gamble and timetrade-off which directly measure the value that patients attach to their health states [6] . Direct utility assessments are typically performed by interview and are time-consuming and typically not feasible in large-scale studies.
There are very limited data with respect to head to head comparisons of the SF-6D and the HUI3 and we are unaware of such data in CKD. The purpose of the study was to assess the within-subject agreement and compare discriminative abilities between the SF-6D and the HUI3 in patients with CKD.
Methods

Measurement Tools
SF-6D. The SF-6D is a preference-based scoring system derived from 11 items from six dimensions ("6D") of the SF-36 covering physical functioning, role limitations, social functioning, pain, mental health, and vitality. Each dimension uses four to six levels where level one represents full functional capacity on a dimension and levels four to six represent the lowest level of functioning on an attribute. The comprehensive health state of an individual at a point in time is defined as a vector composed of one level for each dimension. Health-state valuations were derived for 249 of the possible 18,000 health states using the conceptual and empirical logic of multiattribute utility theory (MAUT) [7] from a general population sample in the United Kingdom using the standard gamble technique. Preference-based scores for living states range from 0.296 to 1.0 with 0.296 representing the worst possible SF-6D health state and 1.0 representing perfect health; the score for dead is 0.0 [5] . A score difference of 0.03 on the SF-6D is generally accepted to be clinically important [8] , although a recent article showed the important clinical difference for the SF-6D to be on average 0.041 across 11 chronic conditions [9] . The SF-6D uses a 4-week recall period.
HUI. This is a family of generic, multiattribute, preferencebased HRQL instruments [3, 10] . The most recent version, the HUI3, uses five or six levels for each of eight attributes (vision, hearing, speech, ambulation, dexterity, cognition, emotion, and pain) [3, 4] . As with the SF-6D, level one represents full functional capacity on an attribute and level five or six represents the lowest level of functioning on an attribute. The preference-based score is computed using MAUT based on preferences of a general population sample in Canada using a visual analog scale (VAS) and the standard gamble technique via a transformation of the VAS. Potential scores range from -0.36 to 1.0 with -0.36 representing the worst possible HUI3 health state, 0.0 representing dead, and 1.0 representing perfect health. The standard 15-item self-completed questionnaire covering both the HUI2 and HUI3 classification systems using a 4-week recall period was employed. A difference of Ն0.03 on the overall score is considered to be clinically important [11] . Nevertheless, differences as small as 0.01 in HUI scores have been considered to be important [11] . US and Canadian population norms are available for comparison [12] [13] [14] .
Beck Depression Inventory II (BDI-II). This is a 21-item, selfreport scale measuring characteristic attitudes and symptoms of depression with total scores ranging from 0 to 63 [15] . The scale has been used extensively in patients with CKD [16] [17] [18] [19] [20] . A recent study showed that the BDI-II cutoff score with the best diagnostic accuracy for depression in CKD when compared to the Structured Clinical Interview for Depression was 14 with a sensitivity of 62% and specificity of 81% [19] .
Charlson Comorbidity Index (CCI) [21] . The CCI was used to quantify comorbidity. It is commonly used in research with CKD patients and has been validated specifically for studies on health status [22] . The CCI is based on weights for each comorbidity and age class. The weights express the associated risk of mortality and are summed to obtain a final score [23] . Comorbidity was defined in terms of presence or absence of disease at the onset of the study for all predialysis CKD patients and in terms of presence or absence of disease at the onset of chronic dialysis treatment for all dialysis patients. A CCI score Ն8 identifies dialysis patients who have approximately a 50% 1-year mortality rate [23] .
Patients and Procedures
The main study is a prospective study designed to determine the psychosocial adjustment to illness, depression, HRQL, and economic outcomes in incident adult chronic dialysis patients and patients with stages 4 and 5 CKD who are clinically anticipated to require dialysis within the next 12 months. Study participants were recruited from eight hemodialysis units and a large university-based renal insufficiency clinic in northern Alberta, Canada between January 2005 and June 2006. The inclusion criteria were 1) stage 4 or 5 CKD with an expected time to dialysis of less than 12 months (based on the clinical judgment of the attending nephrologist); 2) patients who had started chronic hemodialysis within the past 3 months; 3) cognitively able to complete the questionnaires and give informed consent; and 4) able to converse and complete the questionnaires in English.
Patients were consecutively enrolled as they were identified by the renal units. All study participants were prospectively evaluated at baseline using the above assessment tools. The questionnaires were self-completed and administered by mail. Information on demographic characteristics, race, and ethnicity was obtained from self-report from patients who completed a questionnaire with fixed response categories and the opportunity to write in information. All study procedures were approved by the Health Research Ethics Board of the University of Alberta.
Statistical Analyses
Patient characteristics were described as frequencies and percentages or as a mean (SD). Descriptive statistics were obtained for patient characteristics, comorbidity, depression, and HRQL preference-based scores. Weights used to derive SF-6D preferencebased scores were those by Brazier et al. [5] . Weights used to derive preference-based scores from the HUI3 were those by Feeny et al. [4] .
The extent of agreement between the two instruments was examined by comparing the mean preference-based scores using paired t-tests. Visual inspection of the distributions of SF-6D and HUI3 scores suggested that although the distribution for the former was symmetric, the distribution for the latter was skewed. A Levene's test for equality of variances was used to assess the equality of the two variances. Association between the two measures was determined using Pearson productmoment correlation coefficients.
The intraclass correlation coefficient (ICC) was used as a measure of agreement. A strong correlation was defined as greater than 0.50, a moderate correlation as 0.35 to 0.50, a weak correlation as 0.20 to 0.34, and a negligible correlation as 0 to 0.19 as suggested by Guyatt et al. [24] . The pattern of agreement was examined graphically by plotting values obtained for the two instruments.
The distribution of responses across the two descriptive systems, specifically at the top and bottom of the scale for each dimension, was examined to identify possible ceiling or floor effects. The degree of association between the overlapping dimensions of the SF-6D and HUI3 was measured using the Spearman's correlation coefficient.
Two independent samples t-test were used to compare the ability of the SF-6D and HUI3 to discriminate between patient groups differing in burden of comorbidity using a CCI score of Ն8 as a cutoff for high comorbidity, disease severity defined as predialysis versus dialysis dependent, and depressive symptoms using a BDI-II score of Ն14 as the cutoff. For descriptive purposes, age and sex were also added to this analysis. SPSS 15.0 for windows was used to perform statistical analyses. A P < 0.05 was considered statistically significant. Because hypotheses were specified a priori, no adjustment was made for multiple testing.
Results
In total, 185 of the 230 patients approached for the master study (80%) consented to participate. All 185 patients were evaluated at baseline. Patient characteristics can be seen in Table 1 . The study participants were predominantly white (82.7%), had an average age of 63.6 years, had significant comorbidity, and 28% had BDI-II scores Ն14, suggestive of depression. Sixty-six percent of patients were predialysis and 34% were on maintenance hemodialysis. With the exception of race, the study participants were representative of the North American dialysis population [25, 26] . The mean preference-based score for the SF-6D was 0.67 (0.13) compared to 0.58 (0.26) for the HUI3. The difference was clinically and statistically significant (0.09, P < 0.01). Both preference-based scores are very low relative to the general population, indicating substantial burden in HRQL. The SF-6D population norm for community-dwelling subjects is 0.80 for men and 0.77 for women aged 65 to 74 years (0.79 and 0.76 for those 55-64) [12] . HUI3 population norms are 0.82 for men and 0.79 for women aged 65 to 74 years (0.78 and 0.77 for those 55-64) [12] .
There is a strong association between SF-6D and HUI3 preference-based scores (Pearson product-moment correlation coefficient 0.55, 95% CI 0.43-0.65) and moderate agreement with an ICC of 0.44 (Fig. 1) . The SF-6D had a greater spread of values between 0.90 and 1.0 whereas at values lower than 0.7, the HUI3 exhibited a greater spread of values. The Spearman rank correlations between SF-6D dimensions of bodily pain, physical functioning, and mental health and the corresponding HUI3 dimensions of pain, ambulation, and emotion were 0.62 (P < 0.01), 0.47 (P < 0.01), and 0.43 (P < 0.01), respectively.
The distributions of the levels for the attributes of the SF-6D and HUI3 are shown in Tables 2 and 3, respectively. All levels for each dimension of both instruments were used indicating considerable heterogeneity in this population. The SF-6D had a substantial proportion of respondents (23.8-38 .9%) at the ceiling for three of the six dimensions (role limitations, social, and pain). The HUI3, however, had a substantial proportion of its respondents at the ceiling (25.9-88.6%) for six of its eight attributes. This was most noticeable for hearing and speech. Nevertheless, these are the two HUI3 attributes not specifically relevant to CKD. The percentages of respondents reporting full function were 65.4% for dexterity, 45.4% for ambulation, 44.9% for cognition, and 36.2% for emotion. The SF-6D had large floor effects for the dimension role limitations with 35.7% of respondents reported the lowest functioning. The range of proportions of patients at the floor for the remaining five SF-6D dimensions was 4.9% to 7.0%. The HUI3 had essentially no floor effects: no patients were at the lowest level of functioning for four of the eight dimensions, and the remainder fell between 2.2% and 3.2%.
The distributions of the overall preference-based scores for the SF-6D and HUI3 are presented in Figure 2 . As expected, the SF-6D has a normal distribution, and the HUI3 was skewed toward lower values. The Levene's test for equality of variances indicated that the variances of the two distributions are not equal (P < 0.001). The range of SF-6D scores was much smaller compared to HUI3 scores. The HUI3 may have a greater ceiling effect as 9% of participants had a preference score between 0.9 and 1.0 compared to 2% for the SF-6D. Floor effect appears larger with the SF-6D as 16% of respondents had HUI3 scores below that of the lowest SF-6D score.
The discriminative abilities of the SF-6D and HUI3 are compared in Table 4 . Both instruments were able to discriminate between patients based on disease severity and BDI-II scores. The study was underpowered to be able to confirm the ability of either tool to discriminate between patients based on comorbidity. There were clinically important differences for scores for both instruments between groups of patients based on age and sex, although this was statistically significant only for age for the HUI3 which demonstrated lower scores and thus greater disability for patients >55 years. For all categories, the differences in preference scores between groups of patients were greater with the HUI3 than the SF-6D, although due to the wider confidence intervals, this did not reach statistical significance except for depressive symptoms using the BDI-II score (P < 0.01).
Discussion
Determining the relative costs and benefits of different interventions has become a critical issue in optimizing care for patients with CKD. Researchers have therefore begun to use multiattribute HRQL measures to incorporate preferences for different health states and to calculate QALYs and cost-effectiveness. Unfortunately, no gold standard currently exists for preferencebased HRQL measurement. The SF-6D is a relatively new instrument that permits SF-36 data to be transformed into preference-based HRQL scores. Being able to use the SF-6D to obtain HRQL scores may be advantageous in certain circumstances. Nevertheless, the HUI3 is a shorter, simpler tool that has been widely used in numerous patient populations. There are limited data comparing the application of these instruments. This is one of the relatively few studies to compare the application of these two widely used generic preference-based instruments in a chronically ill population such as CKD.
Our findings indicate that there are clinically important differences in the performance of the HUI3 and SF-6D in CKD. There was a clinically important and statistically significant difference in the mean preference values between the two instruments. Although the SF-6D and the HUI3 may measure similar constructs and their scores are strongly correlated, the ICC showed only moderate agreement between their preference-based scores. Despite limited data in the literature comparing the HUI3 and SF-6D, these results are similar with those comparing their application in hospitalized patients undergoing percutaneous coronary intervention (Pearson product-moment correlation coefficient 0.62, ICC 0.40) [27] and in patients being treated for high risk of sudden cardiac death (Pearson product-moment correlation coefficient 0.58, ICC 0.42) [28] .
Differences in how health status are defined and the range of health states each measure intended to cover may account for some of the differences in observed scores between the two 
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instruments. Although the two instruments overlap in the dimensions bodily pain-pain, physical functioning-ambulation, and mental health-emotion, the content of the two measures are clearly different in other aspects. The HUI3 is based on a relatively narrow "within-the-skin" approach to health that focuses on impairments in sensation (vision, hearing, speech), cognition, emotional and physical functioning. It was developed to be applicable in both clinical and general population studies. The SF-36 is based on the broader World Health Organization definition of health and includes role (physical and emotional) limitations, social functioning, and vitality and focuses on the health concerns of a generally healthy population living in the community [1] . Thus, the two measures differ in the range of health conditions each was intended to cover. Furthermore, the underlying definitions of health status differ with respect to the exclusion (HUI3) and inclusion (SF-36) of social interaction as a component of health status. Differences in preference-based scores between the two instruments may also reflect differences in the underlying function form of the scoring systems and differences in how the scoring functions were estimated. The SF-6D health states were directly valued by the standard gamble technique although the HUI3 health states were directly valued by VAS with a subset of states also being valued with the standard gamble. A power function was then used to transform VAS to standard gamble scores. The HUI3 scoring function is based on a multiplicative multiattribute utility function that includes a term to capture the effects of an interaction in preferences among the attributes. In contrast, the SF-6D scoring function relies on a linear additive model that assumes that there are no interactions in preferences among the attributes. For SF-6D, 249 of a possible 18,000 SF-6D health states were valued and the scores were used in regression analyses to estimate linear additive models with the choice of final model being made on the basis of goodness-of-fit and parsimony.
The HUI3 appears less subject to floor effects than the SF-6D and is better able to distinguish lower health states, particularly states considered worse than dead which are not addressed by the SF-6D. For example, seven patients reported health states for which the scores were negative on the HUI3, indicating a health state considered worse than dead by the general population. The corresponding scores for these patients on the SF-6D ranged from 0.38 to 0.59. The clinical implication is that these patients have more disability than the floor of the SF-6D would indicate and if they deteriorate, the SF-6D will not be able to capture this. Conversely, the HUI3 is able to discriminate more precisely among higher levels of impairment, a necessary requirement in a patient population such as advanced CKD given their low HRQL scores. This floor effect of the SF-6D compared to the HUI3 has also been shown in hospitalized patients undergoing percutaneous coronary intervention [27] , patients with intermittent claudication [29] , and patients being treated for high risk of sudden cardiac death [28] . Several other studies have also presented evidence on floor effect problems with SF-36 and/or SF-6D [30] [31] [32] [33] [34] [35] [36] .
The SF-6D appears less subject to ceiling effects than the HUI3 and is better able to distinguish higher health states. For patients with limited disability (particularly preference-based scores >0.90), small improvements in health state may be missed by the HUI3. Nevertheless, the clinical relevance of this in the CKD population is likely limited.
A possible reason for the greater floor effect observed in the SF-6D is that states considered worse than dead were not explored. In contrast, substantial interview time was devoted to quantifying how much worse than dead certain HUI3 health states were. This is one of the reasons that HUI3 scores have more "space" below dead, i.e., below zero. This is a critical issue in CKD where states worse than dead are accepted and often result in patients choosing to withdraw from life-sustaining dialysis. A possible reason for the ceiling effect observed in the HUI3 may be the exclusion of some important HRQL dimensions relevant to this patient population such as vitality, role limitations, and social functioning which are present in the SF-6D. SF-36 also includes items on the ability to engage in vigorous physical activity, whereas HUI3 refers to the ability to get around without any difficulty. In healthy populations, the omission of vigorous physical activity from HUI3 may contribute to ceiling effects; this omission is unlikely to be clinically important in CKD.
There was little disparity between the two instruments in terms of their discriminant properties. Although mean differences between groups were greater for the HUI3, these differences were associated with greater standard deviation and hence did not result in greater statistical significance as compared to those calculated for the SF-6D except for the HUI3's ability to discriminate patients with greater BDI-II score.
Although these data were from nine units across Alberta, the study subjects were primarily white and the results may not be generalizable to the entire CKD population. Work that remains outstanding is a comparison of the difference in preference-based scores over time in response to treatment between these two instruments. Subsequent data from this study will allow us to determine this. This study only compared two preference-based HRQL instruments but future research including other multiattribute preference-based tools such as the EQ-5D may be helpful.
This study provides useful insight into the psychometric properties of the SF-6D and HUI3 with several implications for future preference-based HRQL measurement and economic analyses in CKD. Any comparison between HUI3 and SF-6D preferencebased scores and QALYs should be made with caution in CKD. This is consistent with the limited evidence in the literature which seems to indicate that measures deployed are not interchangeable for use in cost-utility analyses [28, 37] . The HUI3 descriptive system was created with greater simplicity compared to the SF-6D. Nevertheless, despite being briefer, the HUI3 was better able to capture more severe burden of illness with fewer floor effects. Nevertheless, the SF-6D was better at discriminating among subjects at the top range of the scale. This suggests that the HUI3 would be more suitable for measuring the health of populations with more morbidity and disability such as patients with CKD. It remains to be determined whether these differences will remain when one compares within-instrument differences in preference-based scores over time. Researchers must select an instrument sensitive to the health states under investigation.
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